• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性特发性肺神经内分泌细胞增生症的长期影像学随访:多中心经验

Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience.

作者信息

Chung Cécile, Bommart Sébastien, Marchand-Adam Sylvain, Lederlin Mathieu, Fournel Ludovic, Charpentier Marie-Christine, Groussin Lionel, Wislez Marie, Revel Marie-Pierre, Chassagnon Guillaume

机构信息

Department of Radiology, AP-HP. Centre, Hôpital Cochin, 75014 Paris, France.

Université de Paris, 85 Boulevard Saint-Germain, 75006 Paris, France.

出版信息

J Clin Med. 2021 Jun 30;10(13):2950. doi: 10.3390/jcm10132950.

DOI:10.3390/jcm10132950
PMID:34209147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8268818/
Abstract

Diffuse pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare pre-invasive disease whose pathophysiology remains unclear. We aimed to assess long-term evolution in imaging of DIPNECH, in order to propose follow-up recommendations. Patients with histologically confirmed DIPNECH from four centers, evaluated between 2001 and 2020, were enrolled if they had at least two available chest computed tomography (CT) exams performed at least 24 months apart. CT exams were analyzed for the presence and the evolution of DIPNECH-related CT findings. Twenty-seven patients, mostly of female gender ( = 25/27; 93%) were included. Longitudinal follow-up over a median 63-month duration (IQR: 31-80 months) demonstrated an increase in the size of lung nodules in 19 patients (19/27, 70%) and the occurrence of metastatic spread in three patients (3/27, 11%). The metastatic spread was limited to mediastinal lymph nodes in one patient, whereas the other two patients had both lymph node and distant metastases. The mean time interval between baseline CT scan and metastatic spread was 70 months (14, 74 and 123 months). Therefore, long-term annual imaging follow-up of DIPNECH might be appropriate to encompass the heterogeneous longitudinal behavior of this disease.

摘要

弥漫性肺神经内分泌细胞增生(DIPNECH)是一种罕见的侵袭前疾病,其病理生理学尚不清楚。我们旨在评估DIPNECH的影像学长期演变情况,以便提出随访建议。对2001年至2020年间在四个中心经组织学确诊为DIPNECH的患者进行研究,若他们至少有两次间隔至少24个月的胸部计算机断层扫描(CT)检查,则纳入研究。分析CT检查结果中与DIPNECH相关的表现及其演变情况。共纳入27例患者,其中大多数为女性(25/27;93%)。中位随访时间为63个月(四分位间距:31 - 80个月),结果显示19例患者(19/27,70%)的肺结节增大,3例患者(3/27,11%)出现转移扩散。其中1例患者的转移扩散局限于纵隔淋巴结,另外2例患者既有淋巴结转移又有远处转移。基线CT扫描至转移扩散的平均时间间隔为70个月(14、74和123个月)。因此,对DIPNECH进行长期年度影像学随访可能适合该疾病的异质性纵向行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/24d4402cc58c/jcm-10-02950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/96988d68477a/jcm-10-02950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/66d8b5124b2c/jcm-10-02950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/24d4402cc58c/jcm-10-02950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/96988d68477a/jcm-10-02950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/66d8b5124b2c/jcm-10-02950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63da/8268818/24d4402cc58c/jcm-10-02950-g003.jpg

相似文献

1
Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience.弥漫性特发性肺神经内分泌细胞增生症的长期影像学随访:多中心经验
J Clin Med. 2021 Jun 30;10(13):2950. doi: 10.3390/jcm10132950.
2
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.弥漫性特发性肺神经内分泌细胞增生症:常被延误诊断的影像学和临床特征。
AJR Am J Roentgenol. 2020 Dec;215(6):1312-1320. doi: 10.2214/AJR.19.22628. Epub 2020 Oct 6.
3
Radiological-pathological correlation in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): imaging and histopathology.弥漫特发性肺神经内分泌细胞增生症(DIPNECH)的放射病理学相关性:影像学与组织病理学。
Clin Radiol. 2024 Feb;79(2):133-141. doi: 10.1016/j.crad.2023.10.013. Epub 2023 Oct 29.
4
Lung carcinoid tumors with Diffuse Idiopathic Pulmonary NeuroEndocrine Cell Hyperplasia (DIPNECH) exhibit pejorative pathological features.具有弥漫性特发性肺神经内分泌细胞增生(DIPNECH)的肺类癌肿瘤表现出不良的病理特征。
Lung Cancer. 2021 Jun;156:117-121. doi: 10.1016/j.lungcan.2021.04.024. Epub 2021 Apr 30.
5
A Rare Case of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Case Report.弥漫性特发性肺神经内分泌细胞增生症一例:病例报告
Cureus. 2024 Jun 17;16(6):e62527. doi: 10.7759/cureus.62527. eCollection 2024 Jun.
6
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)与生长抑素类似物的作用:病例系列
Lung. 2015 Oct;193(5):653-7. doi: 10.1007/s00408-015-9754-2. Epub 2015 Jun 26.
7
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH): A Case of Indolent Pulmonary Nodules Diagnosed with Robotic-Assisted Navigational Bronchoscopy.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH):一例通过机器人辅助导航支气管镜检查诊断为惰性肺结节的病例
Case Rep Pulmonol. 2021 Dec 10;2021:6312296. doi: 10.1155/2021/6312296. eCollection 2021.
8
A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review.肺类癌肿瘤和弥漫性特发性肺神经内分泌细胞增生症诊治与管理的多学科方法:一项叙述性综述
Transl Lung Cancer Res. 2022 Dec;11(12):2567-2587. doi: 10.21037/tlcr-22-415.
9
DIPNECH: when to suggest this diagnosis on CT.弥漫性特发性肺神经内分泌细胞增生症:何时在CT上提示该诊断
Clin Radiol. 2015 Mar;70(3):317-25. doi: 10.1016/j.crad.2014.10.012. Epub 2014 Nov 22.
10
Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker.CT上弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)的定量气道评估作为一种新型生物标志物
Diagnostics (Basel). 2022 Dec 8;12(12):3096. doi: 10.3390/diagnostics12123096.

引用本文的文献

1
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a little known cause of thoracic lesions.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH):一种鲜为人知的胸部病变病因。
BMJ Case Rep. 2022 Nov 10;15(11):e252788. doi: 10.1136/bcr-2022-252788.
2
A case of multiple lung carcinoid tumors localized in the right lower lobe.一例位于右下叶的多发性肺类癌肿瘤。
Respir Med Case Rep. 2022 May 27;38:101679. doi: 10.1016/j.rmcr.2022.101679. eCollection 2022.

本文引用的文献

1
Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis.弥漫性特发性肺神经内分泌细胞增生症的临床特征:一项回顾性分析
Chest. 2021 Jan;159(1):432-434. doi: 10.1016/j.chest.2020.08.012. Epub 2020 Aug 14.
2
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) with liver metastases.伴有肝转移的弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)。
BMJ Case Rep. 2019 Jun 24;12(6):e228536. doi: 10.1136/bcr-2018-228536.
3
Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience.
弥漫性特发性肺神经内分泌细胞增生症的治疗:综述及单中心经验
Lung. 2018 Oct;196(5):577-581. doi: 10.1007/s00408-018-0149-z. Epub 2018 Aug 25.
4
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)综合征与类癌肿瘤伴/不伴 NECH:一项临床病理、放射学和免疫分子比较研究。
Am J Surg Pathol. 2018 May;42(5):646-655. doi: 10.1097/PAS.0000000000001033.
5
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.肺类癌的外科切除:多中心研究的长期结果-病理 N 状态的重要性,超乎我们想象。
Lung. 2017 Dec;195(6):789-798. doi: 10.1007/s00408-017-0056-8. Epub 2017 Oct 11.
6
Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging.囊性纤维化肺部疾病的早期检测与灵敏监测:改进及更安全成像的前景
Pediatr Pulmonol. 2016 Oct;51(S44):S49-S60. doi: 10.1002/ppul.23537.
7
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome.弥漫特发性肺神经内分泌细胞增生综合征。
Eur Respir J. 2016 Jun;47(6):1829-41. doi: 10.1183/13993003.01954-2015. Epub 2016 Apr 13.
8
DIPNECH: Association Between Histopathology and Clinical Presentation.弥漫性特发性肺神经内分泌细胞增生症:组织病理学与临床表现之间的关联
Lung. 2016 Apr;194(2):243-7. doi: 10.1007/s00408-016-9854-7. Epub 2016 Feb 15.
9
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.肺神经内分泌(类癌)肿瘤:欧洲神经内分泌肿瘤学会专家共识和典型与非典型肺类癌最佳实践建议。
Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2.
10
The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?多灶性肺神经内分泌增生的成人患者的病变谱:诊断弥漫性特发性肺神经内分泌细胞增生症的最小病理标准集是什么?
Hum Pathol. 2015 Feb;46(2):176-81. doi: 10.1016/j.humpath.2014.10.019. Epub 2014 Nov 12.